Unmasking Wolves in Sheep’s Clothing Stroke.ahajournals.org: Carlos A. Molina, MD, PhD; Magdy M. Selim, PhD, MD. May 1, 2012. Patients with TIA are at high risk of short-term stroke, myocardial infarction, and vascular death. Because stroke risk is reduced by immediate medical or surgical intervention, emergent evaluation and treatment is warranted. The Effect of urgent treatment […]
Beckersasc.com: Written by Sabrina Rodak | April 18, 2012 Beginning Jan. 1, 2013, hospitals and health systems will be required to report data on 76 measures for CMS’ Hospital Inpatient Quality Reporting Program to receive full Medicare reimbursement in 2015. The 76 measures feature several new measures from previous years, including eight for stroke care: venous thromboembolism prophylaxis, […]
In New England, Medicare patients from more-polluted areas were more apt to need care WEDNESDAY, April 18 (HealthDay News) — Long-term exposure to fine-particle air pollution may increase older adults’ risk of being hospitalized for lung and heart disease, stroke and diabetes, a new study says. Harvard School of Public Health researchers compared air-quality data […]
Large review also found positive people less likely to suffer stroke. WEDNESDAY, April 18 (HealthDay News) — Being upbeat is good for your heart, a new study suggests. Many previous studies have shown that negative mental states — such as depression, anger, anxiety and hostility — can harm the heart. This Harvard School of Public […]
American Heart Association, Inc: April 18, 2012. A link between oral health and cardiovascular disease has been proposed for more than a century. Recently, concern about possible links between periodontal disease (PD) and atherosclerotic vascular disease (ASVD) has intensified and is driving an active field of investigation into possible association and causality. The 2 disorders […]
Worldwide 56,000-patient registry to assess safety and outcomes associated with antithrombotic treatments RIDGEFIELD, Conn., May 3, 2012 /PRNewswire. Boehringer Ingelheim Pharmaceuticals, Inc. today announced the launch of the GLORIA™-AF Registry Program, the largest prospective observational study in non-valvular atrial fibrillation (NVAF) planned at this time. With a goal of enrolling 56,000 patients, the registry aims to understand […]
Nejm.org: May 2,2012 METHODS We designed this trial to determine whether warfarin (with a target international normalized ratio of 2.0 to 3.5) or aspirin (at a dose of 325 mg per day) is a better treatment for patients in sinus rhythm who have a reduced left ventricular ejection fraction (LVEF). We followed 2305 patients for […]
Ahajournals.org: April 19,2012. Background and Purpose—To date, the association between depressive symptoms and the risk of cardiovascular diseases remains controversial. We investigated prospectively, within the same population, the time course of the association between baseline depressive symptoms and first stroke or coronary heart disease event. Methods—In the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study, […]
Results published in Stroke showed lower absolute ICH mortality rates for PRADAXA compared to warfarin RIDGEFIELD, Conn., April 18, 2012 /PRNewswire. A new retrospective sub-analysis of the 18,113 patient RE-LY® trial showed lower rates of intracranial hemorrhage (ICH), including both fatal and traumatic ICH, for Pradaxa® (dabigatran etexilate mesylate) capsules 150mg taken twice daily compared with warfarin. […]
Circ.ahajournals.org: March 19, 2012. Background—Warfarin is characterized by marked variations in individual dose requirements and a narrow therapeutic window. Pharmacogenetics (PG) could improve dosing efficiency and safety, but clinical trials evidence is meager. Methods and Results—A Randomized and Clinical Effectiveness Trial Comparing Two Pharmacogenetic Algorithms and Standard Care for Individualizing Warfarin Dosing (CoumaGen-II) comprised 2 […]
